Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.47 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Research & Development (2010 - 2026)

Updated

Protagenic Therapeutics, Inc.new's Research & Development came in at $26,904 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 87.7% from $218,343 a year earlier and down 75.5% from the prior quarter.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Research & Development (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Protagenic Therapeutics, Inc.new reported Research & Development of $371,384, down 77.2% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $901,896, up 139.4% from FY2025.

  • Research & Development carries a five-year compound annual growth rate of -4.5% (FY2021 to FY2026).
  • Going back by fiscal year, Research & Development was $376,740 in FY2025, $3.84 million in FY2024 (+25.5%), $3.06 million in FY2023 (+92.8%) and $1.59 million in FY2022 (+39.8%).
  • The fiscal Q2 2027 figure represents the lowest quarterly Research & Development since fiscal Q3 2015.
  • Year-over-year, Research & Development has declined for three consecutive quarters.
  • Business Quant data shows PTIX's Research & Development at $109,925 (Q1 2027), $80,769 (Q4 2026) and $153,786 (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,300.96 Bn 1,274.58 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 691.57 Bn 611.43 Bn 17.30 Bn 4.65 Bn
3 AbbVie 526.86 Bn 494.87 Bn 13.12 Bn 2.57 Bn
4 Merck 365.17 Bn 328.11 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 314.51 Bn 287.74 Bn - -
6 Astrazeneca 288.94 Bn 262.45 Bn 13.26 Bn 3.89 Bn
7 Amgen 254.33 Bn 205.98 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 211.53 Bn 186.64 Bn 6.73 Bn 1.61 Bn
9 Pfizer 166.13 Bn 113.48 Bn 12.56 Bn 3.02 Bn
10 Protagenic Therapeutics, Inc.new 850,797.76 -3.51 Mn - 26,904.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 26,904.00
Jun 30, 2026 109,925.00
Mar 31, 2026 80,769.00
Dec 31, 2025 153,786.00
Sep 30, 2025 218,343.00
Jun 30, 2025 394,112.00
Mar 31, 2025 880,372.00
Dec 31, 2024 134,580.00
Sep 30, 2024 16,964.00
Jun 30, 2024 1.20 Mn
Mar 31, 2024 1.46 Mn
Dec 31, 2023 1.01 Mn
Sep 30, 2023 1.12 Mn
Jun 30, 2023 671,169.00
Mar 31, 2023 348,031.00
Dec 31, 2022 257,520.00
Sep 30, 2022 501,366.00
Jun 30, 2022 160,515.00
Mar 31, 2022 669,838.00
Dec 31, 2021 146,568.00
API Access

Protagenic Therapeutics, Inc.new Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=PTIX&period=max&api_key=YOUR_API_KEY